Filing Flows › Biolargo (BLGO) › Q2 2025
Biolargo (BLGO) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Biolargo (BLGO) reported revenue of $2.8M for the second quarter 2025 (Q2 2025), -45% from a year earlier and -15% from the quarter before. Operating margin was -64.9%, net loss $1.9M (67.8% of revenue).
Biolargo, Q2 2025: revenue $2.8M (-45% year over year), operating margin -64.9%, net loss $1.9M, operating cash flow −$2.1M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8M | -15% | -45% |
| Operating profit | −$1.8M | — | — |
| Net earnings | −$1.9M | — | — |
| Operating cash flow | −$2.1M | — | — |
What changed
Revenue was $2.8M in Q2 2025, down 45% year over year and down 15% from the previous quarter. Product was the largest line at 72% of revenue. Product lost $2.9M year over year (down 59%), 129% of the total change.
Gross margin was 51.2%, up 8.5 points from a year earlier. Operating costs exceeded revenue by $1.8M, an operating margin of -64.9%. Operating expenses grew 6% against a revenue fall of 45%. The fastest-growing cost line was SG&A (+12%). The quarter ended with a net loss of $1.9M, narrower than the previous quarter's $1.9M loss. Minority interests bore $690K of it: to shareholders the quarter was a loss of $1.2M.
Operating cash flow was −$2.1M. Non-cash charges added back $36K of depreciation and $492K of share-based compensation. Working capital and other items used $764K.
Questions
What was Biolargo's revenue in the second quarter 2025?
Biolargo (BLGO) reported revenue of $2.8M for the second quarter 2025 (Q2 2025), -45% from a year earlier and -15% from the quarter before.
Was Biolargo profitable in the second quarter 2025?
Operating loss was $1.8M (-64.9% of revenue) and net loss $1.9M.
Source: Biolargo 10-Q on SEC EDGAR.